Significant racial differences in the key factors associated with early graft loss in kidney transplant recipients

American Journal of Nephrology

Volumn 40, Issue 1, 2014, Pages 19-28

  Taber, David J ^a   Douglass, Kevin ^a   Srinivas, Titte ^b   Mcgillicuddy, John W ^a   Bratton, Charles F ^a   Chavin, Kenneth D ^a   Baliga, Prabhakar K ^a   Egede, Leonard E ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

African American; Cardiovascular disease; Graft loss; Kidney transplantation

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLATE MOFETIL; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT INFECTION; GRAFT RECIPIENT; HOSPITAL READMISSION; HUMAN; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; AFRICAN AMERICAN; BK VIRUS INFECTION; COMORBIDITY; DISABILITY; GRAFT SURVIVAL; KIDNEY DONOR RISK INDEX; MIDDLE AGED; SCORING SYSTEM; AGED; ANALOGS AND DERIVATIVES; BK VIRUS; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; ETHNOLOGY; GRAFT REJECTION; HEALTH DISPARITY; HYPERTENSION; KIDNEY FAILURE, CHRONIC; ODDS RATIO; POLYOMAVIRUS INFECTIONS; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TIME FACTOR; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGED; BK VIRUS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DYSLIPIDEMIAS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH STATUS DISPARITIES; HUMANS; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MEDICARE; MIDDLE AGED; MYCOPHENOLIC ACID; ODDS RATIO; POLYOMAVIRUS INFECTIONS; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS; TACROLIMUS; TIME FACTORS; UNITED STATES;

EID: 84902915724     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000363393     Document Type: Article

References (35)

1. Organ Procurement and Transplantation Network (OPTN) and Scientific Registry of Transplant Recipients (SRTR): OPTN/SRTR 2010 Annual Data Report. Rockville/MD, Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, 2011
2. Opelz G, Mickey MR, Terasaki PI: Influence of race on kidney transplant survival. Transplant Proc 1977; 9: 137-142
3. Terasaki PI, Opelz G, Mickey MR: Summary of kidney transplant data, 1977-factors affecting graft outcome. Transplant Proc 1978; 10: 417-421
4. Ciancio G, Burke GW, Suzart K, Mattiazzi A, Vaidya A, Roth D, Kupin W, Rosen A, Johnson N, Miller J: The use of daclizumab, tacrolimus and mycophenolate mofetil in African-American and Hispanic first renal transplant recipients. Am J Transplant 2003; 3: 1010-1016
5. Neylan JF: Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 kidney transplant study group. Transplantation 1998; 27: 65: 515-523
6. Podder H, Podbielski J, Hussein I, Katz S, Buren C, Kahan BD: Sirolimus improves the two-year outcome of renal allografts in African-American patients. Transplant Int 2001; 14: 135-142
7. Weber M, Deng S, Arenas J, Aradhye S, Grossman R, Shaw L, Naji A, Barker C, Brayman KL: Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy. Transplant Proc 1997; 29: 3669-3670
8. Butkus DE, Meydrech EF, Raju SS: Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med 1992; 327: 840-845
9. Curtis JJ: Kidney transplantation: Racial or socioeconomic disparities?. Am J Kidney Dis 1999; 34: 756-758
10. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S: Noncompliance in organ transplant recipients. Transplantation 1990; 49: 374-377
11. Kalil R, Heim-Duthoy K, Kasiske B: Patients with a low income have reduced renal allograft survival. Am J Kidney Dis 1992; 20: 63
12. Cosio FG, Dillon JJ, Falkenhain ME, Tesi RJ, Henry ML, Elkhammas EA, Davies EA, Bumgardner GL, Ferguson RM: Racial differences in renal allograft survival: The role of systemic hypertension. Kidney Int 1995; 47: 1136-1141
13. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM: Patient survival after renal transplantation. IV. Impact of post-Transplant diabetes. Kidney Int 2002; 62: 1440-1446
14. Cosio FG, Hickson LJ, Griffin MD, Stegall MD, Kudva Y: Patient survival and cardiovascular risk after kidney transplantation: The challenge of diabetes. Am J Transplant 2008; 8: 593-599
15. Young CJ, Kew C: Health disparities in transplantation: Focus on the complexity and challenge of renal transplantation in African-Americans. Med Clin N Am 2005; 89: 1003-1031
16. Malat GE, Culkin C, Palya A, Ranganna K, Kumar MS: African-American kidney transplantation survival: The ability of immunosuppression to balance the inherent pre-And post-Transplant risk factors. Drugs 2009; 69: 2045-2062
17. Young CJ, Gaston RS: African-Americans and renal transplantation: Disproportionate need, limited access, and impaired outcomes. Am J Med Sci 2002; 323: 94
18. Butkus DE, Meydrech EF, Raju SS: Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med 1992; 327: 840-845
19. Navaneethan SD, Singh S: A systematic review of barriers in access to renal transplantation among African-Americans in the United States. Clin Transplant 2006; 20: 769-775
20. Pallet N, Thervet E, Alberti C, Emal-Aglaé V, Bedrossian J, Martinez F, Roy C, Legendre C: Kidney transplant in Black recipients: Are African-Europeans different from African-Americans?. Am J Transplant 2005; 5: 2682-2687
21. Yeates K, Wiebe N, Gill J, Sima C, Schaubel D, Holland D, Hemmelgarn B, Tonelli M: Similar outcomes among Black and White renal allograft recipients. J Am Soc Nephrol 2009; 20: 172-179
22. Chakkera HA, O'Hare AM, Johansen KL, Hynes D, Stroupe K, Colin PM, Chertow GM: Influence of race on kidney transplant outcomes within and outside the Department of Veterans Affairs. J Am Soc Nephrol 2005; 16: 269-277
23. Kaplan B, Schold J, Meier-Kriesche HU: Overview of large database analysis in renal transplantation. Am J Transplant 2003; 3: 1052-1056
24. Schold JD, Srinivas TR, Braun WE, et al: The relative risk of overall graft loss and acute rejection among African-American renal transplant recipients is attenuated with advancing age. Clin Tranpslant 2011; 25: 721-730
25. Sellares J, De Freitas DG, Mengel M, et al: Understanding the causes of kidney transplant failure: The dominant role of antibody-mediated rejection and nonadherence. Am J Transplant 2012; 12: 388-399
26. Pilch NA, Taber DJ, Moussa O, et al: Prospective randomized controlled trial of rabbit antithymocyte globulin with IL-2 receptor antagonist induction therapy in kidney transplantation. Ann Surg 2014; 259: 888-893
27. Binet I, Volker N, Hirsch HH, et al: Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918-922
28. Johnston O, Jaswal D, Gill JS, et al: Treatment of polyomavirus infection in kidney transplant recipients: A systematic review. Transplantation 2010; 89: 1057-1070
29. Chisholm MA, Mulloy LL, Jagadeesan M, Martin BV, DiPiro JT: Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis 2002; 12: 392-397
30. Brugts JJ, Yetgin T, Hoeks SE, et al: The benefits of statins in people without established cardiovascular disease with cardiovascular risk factors: Meta-Analysis of randomised controlled trials. Br Med J 2009; 338: 2376-2383
31. Kelly TN, Bazzano LA, Fonseca VA, et al: Systematic review: Glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med 2009; 151: 394-403
32. Thompson AM, Hu T, Eshelbrenner CL, et al: Antihypertensive treatment and secondary prevention of cardiovascular disease events among person without hypertension. JAMA 2011; 305: 913-922
33. Carpenter MA, Weir MR, Adey DB, House AA, Bostom AG, Kusek JW: Inadequacy of cardiovascular risk factor management in chronic kidney transplantation- evidence from the FAVORIT study. Clin Transplant 2012; 26:E438-E446
34. Pilmore HL, Skeans MA, Snyder JJ, Israni AK, Kasiske BL: Cardiovascular disease medications after renal transplantation: Results from the patient outcomes in renal transplantation study. Transplantation 2011; 91: 542-551
35. Taber DJ, Pilch NA, Meadows HB, McGillicuddy JW, Bratton CF, Chavin KD, Baliga PK, Egede, LE: The impact of cardiovascular disease and risk factor control on ethnic disparities in kidney transplant. J Cardiovasc Pharm Ther 2013; 18: 243-250